Ocular Therapeutix (OCUL) revenue breakdown
By product, Product revenue, net is the largest at 100% of fiscal 2025 revenue, growing 130% a year over 4 years.
Revenue by product
Fiscal years, as Ocular Therapeutix reports them in its 10-K filings; fiscal 2025 total $52M.
| Products | 2016 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Product revenue, net | $2M | $50M | $58M | $63M | $52M | 100% |
| Collaboration revenue | $42,000 | $1M | $573,000 | $262,000 | $128,000 | 0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for OCUL.
Open OCUL in InvestinglyQuestions
Where does Ocular Therapeutix make its money?
In fiscal 2025, by product: Product revenue, net $52M, Collaboration revenue $128,000.
From Ocular Therapeutix's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.